Iktos
Assif Said has a diverse work experience in various companies. In 2016, they worked as an Agent de Production at Le Groupe La Poste. The following year, they were an alternant at KLESIA within the Direction Technique et des Risques, where they automated calculation tasks and participated in the development of a data centralization tool. Assif also designed a database to consolidate multiple databases from different managers.
In 2019, Assif joined Crédit Agricole as a Stagiaire in Data Analytics before becoming a Data Analyst Junior Alternant at Crédit Agricole Assurances, working in the Equipe Innovation of the DOSIP.
Currently, they are a Développeur Full Stack at Iktos, starting in March 2021.
Assif Said completed their Diplôme Européen de Compétence en Anglais in June 2013. Assif then pursued their education at IUT de Vélizy, where they obtained a DUT (Diplôme Universitaire de Technologie) in informatique from 2015 to 2017. Concurrently, they also attended IUT de Vélizy-Villacoublay and completed a DUT in informatique specializing in Informatique. Finally, they attended TELECOM Nancy from 2017 to 2020, where they earned a degree in Ingenieur informatique spécialité SIE.
This person is not in any offices
Iktos
Incorporated in October 2016, Iktos is a start-up company specializing in the development of artificial intelligence solutions applied to chemical research, more specifically medicinal chemistry and new drug design. Iktos is developing a proprietary and innovative solution based on deep learning generative models, which enables, using existingdata, the design of molecules that are optimized in silico to meet all the success criteria of a small molecule discovery project. The use of Iktos technology enables major productivity gains in upstream pharmaceutical R&D. Iktos offers its technology both as a professional services and as a SaaS software platform. Iktos offers Makya™, ligand and structure-based de novo drug design platform for multi-parametric optimisation (MPO) of lead compounds in line with Target Candidate Profile (TCP). Iktos is also developing Spaya™, a synthesis planning software based upon Iktos’s proprietary AI technology for retrosynthesis.